(58) pointed out that CEBPD-triggered hsa-miR-193b-3p directly targets cyclin D1 (CCND1) and ETS proto-oncogene 1 (ETS1) to cause cell cycle G1 arrest, invasive inhibition after CDDP treatment, suggesting that CDDP-induced CEBPD strengthens its tumor suppression. The gene discussed is CEBPD; the disease is neoplasm.